![](https://usercontent.one/wp/medimix.be/wp-content/uploads/sites/3/2023/10/mireille-fontsa.png)
Daily highlight in melanoma & other skin cancers
In the context of the phase 2 SWOG S1801 trial, the efficacy of neoadjuvant-adjuvant administration of pembrolizumab was compared to adjuvant treatment alone, specifically focusing on the achievement of pathological